ADUS - Addus HomeCare Corporation
After hours:
| Previous Close | 88.84 |
| Open | 88.66 |
| Bid | 88.95 x 800 |
| Ask | 91.48 x 800 |
| Day's Range | 88.27 - 89.19 |
| 52 Week Range | 73.66 - 114.99 |
| Volume | |
| Avg. Volume | 154,145 |
| Market Cap | 1.439B |
| Beta (5Y Monthly) | 0.89 |
| PE Ratio (TTM) | 28.65 |
| EPS (TTM) | 3.10 |
| Earnings Date | Jul 31, 2023 - Aug 04, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 113.86 |
ZacksMedtronic (MDT) to Expand Diabetes Care With New Buyout
Medtronic's (MDT) latest acquisition will increase its capacity to assist more individuals with diabetes worldwide within a single, seamless Medtronic support ecosystem.
ZacksHere's Why You Should Retain CVS Health (CVS) Stock for Now
Investors are optimistic about CVS Health (CVS) on continued growth across the entire range of insured and self-insured medical, pharmacy, dental and behavioral health products and services.
Simply Wall St.Investors in Addus HomeCare (NASDAQ:ADUS) have seen favorable returns of 54% over the past five years
Addus HomeCare Corporation ( NASDAQ:ADUS ) shareholders might be concerned after seeing the share price drop 22% in the...
ZacksThermo Fisher (TMO) Expands Manufacturing Facility in APAC
Thermo Fisher (TMO) latest expansion will enable it to better assist clients in accelerating their research, development and marketing of medications and vaccines in the Asia-Pacific region.
Business WireAddus HomeCare to Participate in the 2023 Jefferies Healthcare Conference
FRISCO, Texas, May 24, 2023--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Dirk Allison, Chairman and Chief Executive Officer, and Brian Poff, Executive Vice President and Chief Financial Officer, will participate in the 2023 Jefferies Healthcare Conference, which takes place June 7-9, 2023, in New York City.
ZacksHere's Why Investors Should Add Zimmer Biomet (ZBH) Now
Investors are optimistic about Zimmer Biomet (ZBH) on continued procedure recovery, solid execution and increasing traction around innovations.
- Zacks
QIAGEN (QGEN) Expands Enzyme Offering to Aid Laboratory
QIAGEN is a one-stop shop for all research needs, including solutions for sample preparation, automation and bioinformatics with enzyme offering expansion.
ZacksAbbott (ABT) Expands in Electrophysiology With New FDA Nod
Abbott (ABT) notes that using TactiFlex catheter can lead to reduced procedure times and better safety compared to the company's previous generation catheters.
ZacksHologic (HOLX) Gets FDA Nod for Multiplexed Respiratory Test
Hologic's (HOLX) Panther Fusion SARS-CoV-2/Flu A/B/RSV assay is done using the fully-automated, high-throughput Panther Fusion system.
ZacksAbbott's (ABT) Assert-IQ Cardiac Monitor Receives FDA Approval
Abbott's (ABT) latest approval adds to its line-up of remote patient management and treatment tools that can support doctors more effectively.
- Zacks
STERIS (STE) Continues to Face Dull Dental Sales, Margin Woes
STERIS (STE) competes for pharmaceutical, research and industrial customers against several large companies that have robust product portfolios and global reach.
ZacksEdwards Lifesciences' (EW) TAVR Study Outcome Favorable
Edwards Lifesciences' (EW) latest findings of the study confirm the value of the Edwards Benchmark programme for standardizing clinical pathways for patients undergoing TAVR in Europe.
ZacksHere's Why Investors Should Retain Omnicell (OMCL) Stock Now
Investors are optimistic about Omnicell (OMCL) on its strong execution of strategies, disciplined cost management and revenue timing.
ZacksADUS vs. USPH: Which Stock Is the Better Value Option?
ADUS vs. USPH: Which Stock Is the Better Value Option?
ZacksMedtronic's (MDT) Global Market Share Strong, FX Headwind Stays
Within cardiac rhythm management, Medtronic's (MDT) pacing business continues to outperform the market, banking on strong global growth of its Micra leadless pacemaker family.
ZacksLabCorp (LH) Expands Laboratory Relationship With New Pact
LabCorp's (LH) recent partnership will expand healthcare access, offer advanced diagnostic tools and guarantee that both patients and doctors can afford the treatments they get.
ZacksIs Addus HomeCare (ADUS) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Business WireAddus HomeCare to Participate in the 2023 RBC Capital Markets Global Healthcare Conference
FRISCO, Texas, May 09, 2023--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Dirk Allison, Chairman and Chief Executive Officer, and Brian Poff, Executive Vice President and Chief Financial Officer, will participate in the 2023 RBC Capital Markets Global Healthcare Conference, which takes place May 16-17, 2023, in New York City.
ZacksHere's Why Addus HomeCare (ADUS) is Poised for a Turnaround After Losing -24.6% in 4 Weeks
Addus HomeCare (ADUS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
- Thomson Reuters StreetEvents
Q1 2023 Addus Homecare Corp Earnings Call
Q1 2023 Addus Homecare Corp Earnings Call
Business WireAddus HomeCare to Participate in BofA Securities 2023 Healthcare Conference
FRISCO, Texas, May 02, 2023--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Dirk Allison, Chairman and Chief Executive Officer, Brad Bickham, President and Chief Operating Officer, and Brian Poff, Executive Vice President and Chief Financial Officer, will participate in the BofA Securities 2023 Healthcare Conference, which takes place May 9 –11, 2023, in Las Vegas, Nevada.
ZacksAddus HomeCare (ADUS) Beats Q1 Earnings and Revenue Estimates
Addus HomeCare (ADUS) delivered earnings and revenue surprises of 7.78% and 1.03%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Business WireAddus HomeCare Announces First Quarter 2023 Financial Results
FRISCO, Texas, May 01, 2023--Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the first quarter ended March 31, 2023.
Business WireAddus HomeCare Comments on New Department of Health and Human Services Proposed Rule
FRISCO, Texas, May 01, 2023--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, commented on the proposed new rule announced last week by the Biden Administration’s Department of Health and Human Services (HHS) known as "Assuring Access to Medicaid Services." The proposed rule is in addition to those adopted under the Obama Administration in 2016 and incorporates new requirements covering additional Medicaid Services, including Home and Community-Based Services (HCBS).
ZacksOption Care (OPCH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Option Care (OPCH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.